Hydrogen-Enriched Hyaluronic Acid Dressing Ameliorates Diabetic Foot Ulcer via Promoting Mitophagy.
Ziyu Xu, Xinyu Cui, Houbin Chu, Hao Wan, Yunbo Xie, Ying Wang, Qingbin Ni, Xiaolin Ding, Guohua Song · Journal of diabetes · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In rats, the VSD + H₂ group demonstrated superior efficacy in reducing serum inflammatory markers compared to the VSD group (Figure 1F ), with significantly lower malondialdehyde (MDA) levels and higher superoxide dismutase (SOD) activity at the wound site (Figure 1G ). These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in rats. The VSD + H₂ group demonstrated superior efficacy in reducing serum inflammatory markers compared to the VSD group (Figure 1F ), with significantly lower malondialdehyde (MDA) levels and higher superoxide dismutase (SOD) activity at the wound site (Figure 1G ).
What the Researchers Studied
The researchers studied rats. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Reported treatment duration: 4 weeks. The VSD + H₂ group demonstrated superior efficacy in reducing serum inflammatory markers compared to the VSD group (Figure 1F ), with significantly lower malondialdehyde (MDA) levels and higher superoxide dismutase (SOD) activity at the wound site (Figure 1G ). VSD combined with hydrogen-rich saline significantly enhanced wound healing in patients, while reducing inflammation and oxidative damage. However, both HA and hydrogen significantly induced SIRT3 expression and activated the downstream FOXO3A/PINK1-PARKIN signaling pathway, promoting mitochondrial autophagy and reducing cellular apoptosis.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The reported sample size was 3. The study used a preclinical animal experiment. The reported treatment duration was 4 weeks.
Limitations and Safety
Reported limitations: Wound imaging showed there was no significant difference in wound area between the two groups before and after treatment, which may be attributed to the small sample size and short treatment duration (Figure 1B,C ).
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.